280 related articles for article (PubMed ID: 38669419)
21. Interleukin-6 producing pheochromocytoma/paraganglioma: case series from a tertiary referral centre for pheochromocytomas and paragangliomas.
Meijs AC; Schroijen MA; Snel M; Corssmit EPM
J Endocrinol Invest; 2021 Oct; 44(10):2253-2259. PubMed ID: 33715142
[TBL] [Abstract][Full Text] [Related]
22. The involvement of the adrenergic nervous system in activating human brown adipose tissue and browning.
Pinto YO; Festuccia WTL; Magdalon J
Hormones (Athens); 2022 Jun; 21(2):195-208. PubMed ID: 35247188
[TBL] [Abstract][Full Text] [Related]
23. Pheochromocytoma/paraganglioma crisis: case series from a tertiary referral center for pheochromocytomas and paragangliomas.
Meijs AC; Snel M; Corssmit EPM
Hormones (Athens); 2021 Jun; 20(2):395-403. PubMed ID: 33575936
[TBL] [Abstract][Full Text] [Related]
24. Intrarenal hemodynamics and kidney function in pheochromocytoma and paraganglioma before and after surgical treatment.
Januszewicz M; Dobrowolski P; Januszewicz A; Warchoł-Celińska E; Jóźwik-Plebanek K; Motyl D; Kabat M; Pęczkowska M; Michałowska I; Ambroziak U; Toutounchi S; Gałązka Z; Courcelles L; Pappaccogli M; Eisenhofer G; Persu A; Lenders JWM; Kądziela J; Prejbisz A
Blood Press; 2021 Jun; 30(3):172-179. PubMed ID: 33586556
[TBL] [Abstract][Full Text] [Related]
25. Blood Pressure Profile, Catecholamine Phenotype, and Target Organ Damage in Pheochromocytoma/Paraganglioma.
Petrák O; Rosa J; Holaj R; Štrauch B; Krátká Z; Kvasnička J; Klímová J; Waldauf P; Hamplová B; Markvartová A; Novák K; Michalský D; Widimský J; Zelinka T
J Clin Endocrinol Metab; 2019 Nov; 104(11):5170-5180. PubMed ID: 31009053
[TBL] [Abstract][Full Text] [Related]
26. Distinct uptake of 18F-fluorodeoxyglucose by brown adipose tissue with a catecholamine-secreting tumor.
Sekizawa N; Yoshimoto T; Izumiyama H; Hirata Y
Intern Med; 2010; 49(21):2363. PubMed ID: 21048377
[No Abstract] [Full Text] [Related]
27. Metabolic impact of pheochromocytoma/paraganglioma: targeted metabolomics in patients before and after tumor removal.
Erlic Z; Kurlbaum M; Deutschbein T; Nölting S; Prejbisz A; Timmers H; Richter S; Prehn C; Weismann D; Adamski J; Januszewicz A; Reincke M; Fassnacht M; Robledo M; Eisenhofer G; Beuschlein F; Kroiss M
Eur J Endocrinol; 2019 Dec; 181(6):647-657. PubMed ID: 31614337
[TBL] [Abstract][Full Text] [Related]
28. Chromogranin A in the Laboratory Diagnosis of Pheochromocytoma and Paraganglioma.
Bílek R; Vlček P; Šafařík L; Michalský D; Novák K; Dušková J; Václavíková E; Widimský J; Zelinka T
Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 31027285
[TBL] [Abstract][Full Text] [Related]
29. Energy and metabolic alterations in predisposition to pheochromocytomas and paragangliomas: the so-called Warburg (and more) effect, 15 years on.
Neumann HP; de Herder W
Endocr Relat Cancer; 2015 Aug; 22(4):E5-7. PubMed ID: 26273100
[No Abstract] [Full Text] [Related]
30. Incidence and Clinical Presentation of Pheochromocytoma and Sympathetic Paraganglioma: A Population-based Study.
Ebbehoj A; Stochholm K; Jacobsen SF; Trolle C; Jepsen P; Robaczyk MG; Rasmussen ÅK; Feldt-Rasmussen U; Thomsen RW; Søndergaard E; Poulsen PL
J Clin Endocrinol Metab; 2021 Apr; 106(5):e2251-e2261. PubMed ID: 33479747
[TBL] [Abstract][Full Text] [Related]
31. Addition of 3-methoxytyramine or chromogranin A to plasma free metanephrines as the initial test for pheochromocytoma and paraganglioma: Which is the best diagnostic strategy.
Liu L; Xie W; Song Z; Wang T; Li X; Gao Y; Li Y; Zhang J; Guo X
Clin Endocrinol (Oxf); 2022 Feb; 96(2):132-138. PubMed ID: 34486152
[TBL] [Abstract][Full Text] [Related]
32. Tailored Molecular Imaging of Pheochromocytoma and Paraganglioma: Which Tracer and When.
Di Stasio GD; Cuccurullo V; Cascini GL; Grana CM
Neuroendocrinology; 2022; 112(10):927-940. PubMed ID: 35051937
[TBL] [Abstract][Full Text] [Related]
33. New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification.
Crona J; Taïeb D; Pacak K
Endocr Rev; 2017 Dec; 38(6):489-515. PubMed ID: 28938417
[TBL] [Abstract][Full Text] [Related]
34. Disease monitoring of patients with pheochromocytoma or paraganglioma by biomarkers and imaging studies.
Schreiner F; Beuschlein F
Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101347. PubMed ID: 31662271
[TBL] [Abstract][Full Text] [Related]
35. Gene Profile of Adipose Tissue of Patients with Pheochromocytoma/Paraganglioma.
Klímová J; Mráz M; Kratochvílová H; Lacinová Z; Novák K; Michalský D; Kvasnička J; Holaj R; Haluzíková D; Doležalová RP; Zítek M; Krátká Z; Todorovová V; Widimský J; Haluzík M; Zelinka T; Petrák O
Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327387
[TBL] [Abstract][Full Text] [Related]
36. Clinical Presentation and Treatment Outcomes of Children and Adolescents With Pheochromocytoma and Paraganglioma in a Single Center in Korea.
Park H; Kim MS; Lee J; Kim JH; Jeong BC; Lee S; Lee SK; Cho SY; Jin DK
Front Endocrinol (Lausanne); 2020; 11():610746. PubMed ID: 33584544
[TBL] [Abstract][Full Text] [Related]
37. Retinal arterial remodeling in patients with pheochromocytoma or paraganglioma and its reversibility following surgical treatment.
Gosk-Przybyłek M; Doroszko A; Dobrowolski P; Warchoł-Celińska E; Harazny J; Bińczyk E; Szymanek K; Pęczkowska M; Kabat M; Toutounchi S; Gałązka Z; Górnicka B; Szaflik J; Januszewicz M; Klisiewicz A; Hoffman P; Lenders JWM; Eisenhofer G; Szaflik JP; Schmieder RE; Prejbisz A; Januszewicz A
J Hypertens; 2020 Aug; 38(8):1551-1558. PubMed ID: 32205562
[TBL] [Abstract][Full Text] [Related]
38. The utility of
Jaiswal SK; Sarathi V; Malhotra G; Hira P; Shah R; Patil VA; Dalvi A; Prakash G; Lila AR; Shah NS; Bandgar T
J Pediatr Endocrinol Metab; 2021 Jan; 34(1):109-119. PubMed ID: 33180042
[TBL] [Abstract][Full Text] [Related]
39. Biochemical Diagnosis of Catecholamine-Producing Tumors of Childhood: Neuroblastoma, Pheochromocytoma and Paraganglioma.
Eisenhofer G; Peitzsch M; Bechmann N; Huebner A
Front Endocrinol (Lausanne); 2022; 13():901760. PubMed ID: 35957826
[TBL] [Abstract][Full Text] [Related]
40. TAKOTSUBO-LIKE CARDIOMYOPATHY IN A LARGE COHORT OF PATIENTS WITH PHEOCHROMOCYTOMA AND PARAGANGLIOMA.
Gagnon N; Mansour S; Bitton Y; Bourdeau I
Endocr Pract; 2017 Oct; 23(10):1178-1192. PubMed ID: 28704094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
